The loss of tight control of the NF-κB pathway leads to a shift in the cellular response related to cell cycle, proliferation, and apoptosis, which are key pathways in CRC as well as modulation in the tumor immune microenvironment associated with CRC. The gene discussed is NFKB1; the disease is colorectal carcinoma.